Psychosis: Early Detection, Intervention and Prevention (EDIP)
Primary Purpose
Prodromal Schizophrenia, Psychotic Disorders, Severe Bipolar Disorder With Psychotic Features
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Family-aided Assertive Community Treatment
Enhanced standard treatment
Sponsored by
About this trial
This is an interventional prevention trial for Prodromal Schizophrenia focused on measuring Prodromal, Schizophrenia, Psychosis, Family psychoeducation, Assertive community treatment, Supported employment, Supported education
Eligibility Criteria
Inclusion Criteria:
- Prodromal psychotic symptoms
- Age 12-35
- In catchment area (greater Portland, Maine)
Exclusion Criteria:
- Previous or current psychotic episode
- IQ less than 70
- Outside catchment area
- Toxic psychosis
Sites / Locations
- Maine Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Family-aided Assertive Community Treatment
Enhanced standard treatment
Arm Description
The experimental treatment is a combination of family psychoeducation, assertive community treatment, supported education/employment and psychotropic medication.
In this arm, the subjects will receive the same psychotropic drugs, but will receive individual case management, family education and crisis intervention.
Outcomes
Primary Outcome Measures
Onset of Psychosis
Onset of psychosis is defined as an event--a new psychotic episode with loss of insight, meeting a score criterion of 6 for one month on the Scale of the Prodromal Syndrome (SOPS), in which full psychosis is defined as havng one score or 6, on a scale of 0 to 6, with 0 representing no psychotic symptoms, and 6 representing full psychosis on any of 5 dimensions of psychosis. The assessemnt is based on the Structrued Interview for the Prodromal Syndrome (SIPS), w widely used instrument for assessing risk of psychosis in adolescents and young adults.
Secondary Outcome Measures
Functioning
Global Assessment of Functioning scale (GAF) at 24 months to assess functioning in symptom, role and social relationships. Global Assessment of Functioning is a widely used scale based on a Likert-keyed score assigned by an interviewer or clinician, based on a scale of 0-100, with 100 being the highest level of functioning.
Full Information
NCT ID
NCT01597141
First Posted
May 9, 2012
Last Updated
January 7, 2016
Sponsor
MaineHealth
Collaborators
Columbia University, Harvard University, University of California, Irvine
1. Study Identification
Unique Protocol Identification Number
NCT01597141
Brief Title
Psychosis: Early Detection, Intervention and Prevention
Acronym
EDIP
Official Title
Psychosis: Early Detection, Intervention and Prevention
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
May 2003 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
MaineHealth
Collaborators
Columbia University, Harvard University, University of California, Irvine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The primary aim of this application is to conduct a randomized, controlled clinical trial of a specialized mental health service delivery system specifically developed for prodromal psychotic disorders. The intervention is Family-aided Assertive Community Treatment (FACT). The goal of the treatment is prevention of psychosis and disability. This study will assess experimentally the clinical effectiveness of this new type of mental health service. Other domains of outcome include cognitive dysfunction and functional disability.
Detailed Description
The proposed study will be part of a larger program, Portland Identification and Early Referral (PIER), under foundation, NIH and Center for Mental Health Services sponsorship, that has established a population-based system of early detection for Greater Portland, Maine. Previous and present effort has educated and trained the community-at-large and all health, education and other professionals, with the result that referrals are occurring at the expected frequency. The principal strategy is to intervene early, prior to onset, in the course of the onset of psychotic disorders to arrest the development of psychotic symptoms and functional disability. The test treatment is a specialized combination of psychoeducational multifamily group and assertive community treatment.
The project will support a team of clinical staff with the ability to: a. foster detection of prodromal disorders in the Greater Portland community by general practitioners, guidance counselors, mental health professionals and the general public; b. accurately assess individuals at high risk for psychosis; c. reliably deliver an evidence-based psychosocial and, if indicated, pharmacological treatment package using standardized methodology. The research study will test, in a randomized controlled trial, the symptomatic and functional outcome of treatment in 100 subjects ages 12 to 35 identified by that system. It will allow the analysis of key social factors contributing to psychosis and their interaction with the treatment conditions and each other.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prodromal Schizophrenia, Psychotic Disorders, Severe Bipolar Disorder With Psychotic Features, Severe Major Depression With Psychotic Features
Keywords
Prodromal, Schizophrenia, Psychosis, Family psychoeducation, Assertive community treatment, Supported employment, Supported education
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Family-aided Assertive Community Treatment
Arm Type
Experimental
Arm Description
The experimental treatment is a combination of family psychoeducation, assertive community treatment, supported education/employment and psychotropic medication.
Arm Title
Enhanced standard treatment
Arm Type
Active Comparator
Arm Description
In this arm, the subjects will receive the same psychotropic drugs, but will receive individual case management, family education and crisis intervention.
Intervention Type
Behavioral
Intervention Name(s)
Family-aided Assertive Community Treatment
Intervention Description
The experimental treatment is a combination of family psychoeducation, assertive community treatment, supported education/employment and psychotropic medication.
Intervention Type
Behavioral
Intervention Name(s)
Enhanced standard treatment
Intervention Description
In this arm, the subjects will receive the same psychotropic drugs, but will receive individual case management, family education and crisis intervention
Primary Outcome Measure Information:
Title
Onset of Psychosis
Description
Onset of psychosis is defined as an event--a new psychotic episode with loss of insight, meeting a score criterion of 6 for one month on the Scale of the Prodromal Syndrome (SOPS), in which full psychosis is defined as havng one score or 6, on a scale of 0 to 6, with 0 representing no psychotic symptoms, and 6 representing full psychosis on any of 5 dimensions of psychosis. The assessemnt is based on the Structrued Interview for the Prodromal Syndrome (SIPS), w widely used instrument for assessing risk of psychosis in adolescents and young adults.
Time Frame
From date of randomization until the date of first documented onset of psychosis, assessed up to 60 months
Secondary Outcome Measure Information:
Title
Functioning
Description
Global Assessment of Functioning scale (GAF) at 24 months to assess functioning in symptom, role and social relationships. Global Assessment of Functioning is a widely used scale based on a Likert-keyed score assigned by an interviewer or clinician, based on a scale of 0-100, with 100 being the highest level of functioning.
Time Frame
24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Prodromal psychotic symptoms
Age 12-35
In catchment area (greater Portland, Maine)
Exclusion Criteria:
Previous or current psychotic episode
IQ less than 70
Outside catchment area
Toxic psychosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William R McFarlane, M.D.
Organizational Affiliation
MaineHealth
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maine Medical Center
City
Portland
State/Province
Maine
ZIP/Postal Code
04102
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
24632857
Citation
McFarlane WR, Susser E, McCleary R, Verdi M, Lynch S, Williams D, McKeague IW. Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention. Psychiatr Serv. 2014 Oct;65(10):1194-200. doi: 10.1176/appi.ps.201300336.
Results Reference
background
PubMed Identifier
23434505
Citation
Woodberry KA, McFarlane WR, Giuliano AJ, Verdi MB, Cook WL, Faraone SV, Seidman LJ. Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis. Schizophr Res. 2013 May;146(1-3):87-94. doi: 10.1016/j.schres.2013.01.017. Epub 2013 Feb 22.
Results Reference
background
PubMed Identifier
20439374
Citation
McFarlane WR, Cook WL, Downing D, Verdi MB, Woodberry KA, Ruff A. Portland identification and early referral: a community-based system for identifying and treating youths at high risk of psychosis. Psychiatr Serv. 2010 May;61(5):512-5. doi: 10.1176/appi.ps.61.5.512.
Results Reference
result
Links:
URL
http://www.preventmentalillness.org
Description
Describes risk factors for psychosis, current scientific understanding of psychosis and means of accessing services
Learn more about this trial
Psychosis: Early Detection, Intervention and Prevention
We'll reach out to this number within 24 hrs